Nvidia, Eli Lilly Partner for $1 Billion AI Drug Lab in Silicon Valley
Technology
C
CNBC TV18•13-01-2026, 13:20
Nvidia, Eli Lilly Partner for $1 Billion AI Drug Lab in Silicon Valley
- •Nvidia and Eli Lilly & Co. are investing $1 billion over five years in a new AI drug laboratory.
- •The facility in Silicon Valley aims to accelerate AI adoption in the pharmaceutical industry.
- •Nvidia seeks to expand its market beyond core tech customers by targeting healthcare and pharma.
- •The lab will integrate AI engineers with Lilly's expertise to automate drug discovery and research.
- •Nvidia is also developing open-source AI models for healthcare and collaborating on lab automation with Thermo Fisher Scientific and Multiply Labs.
Why It Matters: Nvidia and Eli Lilly's $1 billion AI lab aims to revolutionize drug discovery through automation.
✦
More like this
Loading more articles...
